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Summary: A method for the measurement of uric acid in human serum by isotope dilution-mass spectrometry
is described. The analytical procedure consists of the following Steps:
(1) Addition of [l,3-15N2]uric acid to the serum sample;
(2) ion exchange chromatography on AG1-X2;
(3) formation of the trimethylsilyl derivative;
(4) gas liquid chromatography-mass spectrometry (GC-MS), selected ion monitoring (SIM) at m/z-values
456 and 458;
(5) calculation of the amount of uric acid in the serum sample from the isotope ratio, äs measured by GC-
MS.
The accuracy of the method is obtained by the use of the highly specific technique of selected ion recording
in combination with the exact control of recovery äs performed by the isotope dilution procedure. On the
basis of the high accuraey of the isotope dilution-mass spectrometry technique, the method presented here
may be proposed äs a definitive method in clinical chemistry.
The imprecision of the method was estimated by measuring replicates in 18 lyophilised serum pools on
different occasions. The coefficient of Variation proved to be between 0.6 and 1.1% in the concentration
ränge of 200 to 500 / . The lower limit of detection (ratio of signal to noise 3:1) of SIM was about 10 ng
uric acid per sample.
Bestimmung von Harnsäure im menschlichen Serum mit Hilfe der massenspektrometrischen Isotopenverdünnungs-
analyse
Definitive Methoden in der Klinischen Chemie, III
Zusammenfassung: Es wird eine Methode zur Messung von Harnsäure in menschlischem Serum mit der
massenspektrometrischen Isotopenverdünnungsmethode beschrieben. Das Analysenverfahren umfaßt folgende
Schritte:
(1) Zugabe von [l,3-15N2]Harnsäure zu der Serumprobe;
(2) lonenaustauschchromatographie an AG1-X2;
(3) Bildung des Trimethylsilylderivats;
(4) Gaschromatographie-Massenspektrometrie, massenspezifische Detektion bei den m/z-Werten 456 und
458;
(5) Berechnung der Menge an Harnsäure in der Serumprobe aus dem massenspektrometrisch ermittelten
Isotopenverhältnis.
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Die Richtigkeit der Methode wird durch die Anwendung der hochspezifischen Technik der massenselektiven
Aulzeichnung charakteristischer Ionen in Kombination mit dem Isotopenverdünnungsverfahren erreicht. Auf
Grund der hohen Richtigkeit der massenspektrometrischen Isotopenverdünnungsanalyse kann die hier
vorgestellte Methode als Definitive Methode in der Klinischen Chemie vorgeschlagen werden.
Die Impräzision wurde durch Mehrfachanalysen von 18 lyophilisierten Serumpools an verschiedenen Tagen
ermittelt. Der Variationskoeffizient lag im Bereich von 0,6 bis 1,1% bei einem Konzentratiopsbereich von 200
bis 500 / . Die untere Nachweisgrenze der massenselektiven Detektion (bei einem Signal-zu-Rausch-
Verhältnis 3:1) beträgt etwa 10 ng Harnsäure pro Probe.
Introduction
Many methods for the determination of uric acid in
human serum have been proposed in clinical chem-
istry. The most commonly used procedures are the
colour reaction with phosphotungstic acid (1), the
enzymatic reaction with uricase (2, 3) and the
combined enzymatic reactions with uricase and cata-
lase (4) äs well äs with uricase and aldehyde
dehydrogenase (5, 6, 7). More recently, procedures
which are based on the enzymatic reaction with
uricase (8) äs well äs on the technique of mass
fragmentography (9, 10, 11) have been proposed äs
reference methods.
Vast difference between the results of various routine
methods applied to the same serum sample have been
observed (12). This fact is also obvious from the
different method-dependent target values of external
quality control surveys of the Deutsche Gesellschaft
für Klinische Chemie. Therefore it became necessary
to develop reference and definitive methods in order
to provide a reliable basis for comparison and im-
provement of procedures for the measurement of uric
acid. Furthermore, the use of definitive or reference
method values äs target values in external quality
control surveys may be considered äs an invaluable
aid for improving accuracy in the clinical chemical
analysis of uric acid in general. They would help to
direct the results of all laboratories more and more
towards "true values", not only in external quality
control but also in routine work.
Principle of the Method
A defmite amount of isotopically labelled uric acid is
added to a serum sample containing an unknown
amount of the non-labelled substance, both of which
are purified by ion exchange chromatography and
then converted to the trimethylsilyl derivates. The
rätio of non-labelled to labelled substance is measured
by combined gas chromatography-mass spectrornetry
using the selected ion monitoring technique. The
unknown amount of uric acid in the serum sample is
calculated from the isotope ratio.
Materials and Procedure
Reagents
Uric acid (purity 99.7%) is obtained äs a Standard reference
material from the National Bureau of Standards, Washington,
USA. [l,3-l5N2]Uric acid (99% 15N) and [2-l4C]uric acid, speäfk
radioactivity 2.22 GBq/mrnol, are obtained from Amersham
Buchler, Braunschweig, FRG. Aniqn exchange resin (AG1-
X2, acetate form, 200-400 mesh) was suppiied by BioRad,
München, FRG. N-Methyl-N-trimethylsilvl-trifluoroacetic
amide (MSTFA) is a product of Macherey & Nagel, Düren,
FRG. Dried pyridine (Merck, Darmstadt, FRG) is stored over
molecular sieve 4Ä (Merck). All solvents are of analytical grade
or distilled prior to use.
Glassware
A Volumetrie flask used for the preparation of the uric acid
Standard solution is calibrated by adjüsting the flask to the
calibration mark with water at 20°C and weighing the Contents.
Taking into regard the density pf water at this ternperatüre the
flask has a volume of 99.689 ml. For the sampling of serum äs
well äs for dispensing the non-labelled Standard solution a
mechanised pipettor (Hamilton Microlab P, Bonaduz, Switzer-
land) equipped with a gas-tight 2.5 ml syringe is calibrated by
weighing defmite amounts of water at iO°C. For pipetting of
the [l,3-15N2]uric acid Standard solution a 25 -syringe (SGE,
Melbourne, Australia) equipped ,with a repeating adaptor is
used. The precision of the pipetting procedure usiiig the syringe
and the Hamilton pipettor is measured by weighing appropriate
samples of water ten times at 20°C. The loss of water during
the weighing procedure, due to evaporation, is corrected by
weighing the water samples 45 and 90 s after emptying and
calculating the original weight at 0 s. The imprecision of the
Hamilton pipettor is aböut 0.03% (coefficient of Variation, CV)
and of the syringe at 0.3%.
Weighing Procedure
The uric acid certified reference material and the water samples
for calibrating the syringe äs well äs the Hamilton pipettor are
weighed with an ejectronic balance (model 4503, Sartorius,
Göttingen, FRG). The Volumetrie flask is calibrated with the
use of a mechanical balance (model 2432, Sartorius, Göttingen,
FRG). The accuracy of the balänces is ascertained by weighing
officially calibrated test weights.
Instruments and Settings
A Finnigan 1020 combined gaschromatograph-mass spec-
trometer-computer system (Finnigan , Bremen, FRG)
equipped with a fused silica capillary column coated with :S'E-
30 (length 25m, internal diameter 0.32mm, film thickness
. , Macherey & Nagel, Düren, FRG) is emplöyed. The
temperature öf the colurnn oven is set to 190—240 °C with -a
programmed rate of 4°C/min. Helium is used äs carrier gas at
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an inlet pressure of 35 kPa. Samples are injected by the use of
an inlet Splitter device, obtained from Gerstel, M lheim, FRG.
The split ratio is set to a value of about 1:10; the temperature
of the inlet is set to 240°C. During the first 90 s of gas
chromatography the reagents injected are sucked off at the end
of the column with the use of a divert valve in order to protect
the mass spectrometer from excess of solvent. Electron impact
ionisation is used for mass spectrometry. The ionisation energy
is 70 eV. With the selected ion recording mode the resolution
of the mass spectrometer is set to approximately 400 (10%
valley definition).
For the recording of mass spectra the Instrument is scanned in
the r nge from m/z 50 to 400; the resolution is adjusted to about
800.
For the measurement of radioactivity an LB282 Linear
Analyzer (Berthold, Wildbad, FRG) is used.
Preparation of Standard Solutions
For the preparation of the uric acid Standard solution, a specified
amount of the certified reference uric acid preparation (purity
99.7%, estimated inaccuracy 0.1%) within the r nge of 1.9 to
2.1 mg (e. g. 2.056mg) is dissolved with 0.015mol/l ammonia
solution in the calibrated Volumetrie flask at 20°C. The weight
is multiplied by the factor 0.997 to correct for the impurities s
stated in the certificate and by the factor of 0.99689 to correct
for the calibrated volume of the flask, thus yielding a con-
centration of 20.435 μg/ml. This Standard solution must be
prepared each day that i t is needed.
To prepare the [l,3-i5N2] ric acid Standard solution about
2.5mg of the labelled uric acid is dissolved in 10ml 0.015
mol/1 ammonia solution using an ultrasonic bath. The labelled
working solution is stored in quantities of l ml at — 20°C. For
each individual analytical series a vial of l ml of labelled uric
acid solution is equilibrated to room temperature.
Preparation of Standards
For the calibration of the mass spectrometer three Standards
with different concentrations of uric acid are used:
Standard l consists of a mixt re of 20 μΐ of the labelled uric
acid solution (pipetted with the use of the 25 μΐ syringe equipped
with a repeating adaptor which is fixed to 20 μΐ) and 225 μΐ of
the non-labelled uric acid Standard solution.
Standard 2 comprises 20 μΐ of the labelled uric acid Standard
solution and 300 μΐ of the non-labelled working solution.
Standard 3 is composed pf 20 μΐ labelled and 375 μΐ non-labelled
uric acid solution.
Each of the three different Standard mixtures is prepared in
triplicate. The 225, 300 and 375 μΐ aliquots of the non-labelled
certified reference material are sampled with the aid of the
Hamilton Microlab P-pipettor. The Instrument is calibrated
prior to use by sampiing and weighing appropriate amounts of
water 10 times for each volume. The exact volumes were
225.824 μΐ ± 0.07 μΐ (s.d.), 300.319 μΐ ± 0.1 μΐ (s.d.) and
375.309 μΐ ± 0.1 μΐ (s. d.), respectively. From this calibration,
it is deduced that Standard l contains 4.6147 μg, Standard 2
6.1370 μg and Standard 3 7.6694 μg of the uric acid reference
material. Using the aforegoing calibration procedure it is not
.necessary to knpw the accurate amount of labelled uric acid;
however, care should be taken that equal amounts of the labelled
substance are present in the serum samples s well s in the
Standards. For this purpose the sarae syringe equipped with the
repeating adaptor is used for dispensing the labelled material
to samples and Standards, The mixtures of labelled and non-
labelled uric acid solution are evaporated to dryness in a stream
of nitrogen at 60 PC.
Sample Preparation
Serum samples containing about 5 μg uric acid (the approximate
concentration of uric acid is estimated in a preliminary ex-
periment) are sampled and diluted with water to a final volume
of 0.5 ml with the use of the calibrated Hamilton P pipettor.
Twenty μΐ of the [l,3-15NJuric acid solution are added to the
serum samples with the use of the 25 μΐ syringe. The labelled
and non-labeiled uric acid is equilibrated by gently shaking the
mixt re for 30 min at room temperature.
Small columns are prepared by filling the anion exchange resin
into Pasteur pipettes to a height of 2.5 cm and washing the
material with water. The diluted serum samples spiked with the
labelled uric acid are then poured on to the columns. The ion
exchange resin is washed with 2 ml water and 0.5 ml acctic acid
(12 mol/1). Uric acid is finally eluted from the column with the
addition of l ml acetic acid (12 mol/1). The eluate is evaporated
to dryness in a stream of nitrogen at 80°C. The residue is
dissolved in l ml methanolic ammonia solution (mixture of
20 ml 25% aqueous ammonia solution and 80 ml methanol).
The methanolic solution is decanted into a tapered test tube
and evaporated in a stream of nitrogen at 60°C.
The recovery of uric acid after the ion exchange ehromatography
is about 65% s determined by counting the radioactivity in a
sample spiked with l4C-labelled uric acid.
Derivative Formation
The dry residues of Standards and samples are reacted with 50 μΐ
of a mixture of MSTFA and pyridine (1+1, by vol.). The
reaction is carried out at 60°C for at least 12 h.
Gas Chromatography-Mass Spectrometry
Aliquots in the r nge of l to 3 μΐ of the reaction mixtures are
injected into the combined gas chromatograph-mass spec-
trometer. The quadrupole mass filter of the Instrument is
scanned over two small mass ranges. The lower mass r nge is
set from — 0.25 to + 0.25 mass units from the peak center of
the molecular ion of the trimethylsilyl derivative of uric acid
(m/z 456) and the higher mass r nge is adjusted between ± 0.25
mass units from the peak center of the trimethylsilyl derivative
of the labelled uric acid (m/z 458). The exact position of the
peak centers of the molecular ions is measured in a separate
run prior to a series of quantitative analyses. During gas
ehromatography of Standards and samples the mass spec-
trometer repetitively Switches between the two mass ranges
adjusted. Each mass r nge is scanned over a period of 0.134 s;
a complete recording cycle of the two pre-selected masses takes
about 0.280 s. The intensity Signals are recorded on a magnetic
disk of the Computer System. From the intensity data, recorded
on the disk, selected ion chromatograms at m/z 456 and 458
may be reconstructed on the Computer terminal display for
visual inspection. Furthermore the Computer quantitates the
Signals obtained during selected ion recording and prints a
report of the peak height and peak area determination at the
two m/z-values.
In order to keep the stability of the gas chromatography-mass
spectrometry System under continuous control it is important
to analyse serum samples and Standards alternately.
Calculation Procedure
The concentration of uric acid in the serum samples is calculated
from the isotope ratios measured by selected ion recording.
Unfortunately» the commercially available l5N-labelled uric acid
contains small amounts of non-labelled substance. Thcrefore, a
sample which is free of uric acid still gives risc to an isotope
ratio higher than 0. Furthermore, a small amount of naturally
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occurrinc isotopes is prescnt in non-labelled uric acid which
coniributes to the M + 2 signal of the uric acid derivative. This
results in a non-linear relationship between the concentration
of uric acid and the isotope ratio measured by selected um
recording. Taking these two facts into account, an equation lor
the calculation of the results is developed which is descnbed
and discussed in detail in the first paper of this senes on the
determination of Cortisol (13).
Accuracy
The accuracy of the method applied here is achieved
by using the highly specific technique of selected ion
monitoring in combinatioh with the isotope dilütion
principle which is the most suitable procedure for
monitoring recovery.
Precision
The precision of the procedure was determined by
measurements on different occasions, of uric acid in
control sera used by the Deutsche Gesellschaft für
Klinische Chemie for external quality control. For
this purpose 5 vials of a control serum were re-
constituted with 5 ml distilled water. The Contents of
the vials were pooled and shaken gently for two hours
at room temperature. Then quantities of l ml of the
reconstituted serum pool were stored in a deep freeze
until use. For each meäsurement occasion one vial of
the pool was thawed and allowed to attain room
temperature. By applying this procedure the neat
method — dependent Standard deviation is obtained,
thereby excluding any additional vial to vial vari-
ability. As shown in table l the coefficient of Variation
is between 0.6 and 1.1%.
Tab. 1. Parameters of precision of the isotope dilution-mass
spectrometry method for the determination of uric acid
in human serum.
Serum
pool
281
324
383
279
381
322
280
323
382
276
319
378
380
379
278
321
320
277
Uric acid
( / )
199.3
217.1
220.1
252.8
274.8
275.4
312.9
320.6
328.9
397.3
400.9
411.0
415.2
424.7
429.4
446.7
499.0
513.9
n
6
6
10
6
6
6
6
6
10
8
6
6
10
7
6
6
8
6
Standard
deviation
( / )
1.40
1.52
1.76
2.78
3.00
2.75
2.19
3.53
2.30
3.96
3.21
3.29
3.75
4.67
4.30
2.68
3.00
3.10
Coefficient
of Variation
(%)
0.7
0.7
0.8
1.1
1.1
1.0
0.7
1.1
0.7
1.0
0.8
0.8
0.9
1.1
1.0
0.6
0.6
0.6
Sensitivity
The sensitivity of the selected ion monitoring tech-
nique for the detection of uric acid may be estimated
from the lower limit of detection of the mass
spectrometer. The molecular ion of the uric acid
derivative can be detected with a signal to noise ratio
of 3: l when a sample of about 10 ng is injected. It
should be noted that a 500-fold amount is injected
after processing a serum sample.
Discussion
Since it has been generally accepted that high serum
levels of uric acid are the root cause of gout, numerous
methods for the meäsurement of uric acid have been
developed. These are mainly based on colour reactions
with phosphotungstic acid (1), on enzymatic reactions
involving uricase (2) and combined reactions with
uricase and catalase (4) or aldehyde dehydrogenase
(5, 6, 7). As seen from the external quality control
surveys of the Deutsche Gesellschaft für Klinische
Chemie the results obtained from different methods
vary significantly. Therefore, at present several
method-dependent target values have to be
determined before a collaborative survey is performed
and the results of the participants must be evaliiated
in several method-dependent gröups with reference
to the different methodological principles and target
values. Moreover, different reference values, accord-
ing to the different methods in use, müst be applied
in diagnosis and disease control. In view of these
drawbacks of the present quality control System in
clinical chemistry it may be of great advantage to
introduce a reference method, and to use definitive
values äs target values for external quality control
(14). In the present investigation an isotope dilütion
mass spectrometry procedure for the determination
of uric acid was developed thus fulfilling the criteria
for a definitive method. Some of the methodological
details, such äs the formation of the trimethylsilyl
derivative and the pre-pürification with an ion
exchange resin, are similar to the procedure of Walker
(11) and of Öhman (10) who reported the development
of a reference method.
A necessary pre-requisite for the development of a
definitive method is the availability of the compound
to be determined äs a prirnary reference material of
known purity. In this case the substance was obtained
from the National Bureau of Standards, Washington
äs a certified reference material. Furthefmore, [1,3-
15N2]uric acid was commercially available äs an isotop-
ically labelled internal Standard material suitable for
the isotope dilütion technique.
 % jFhis substance was
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added to the serum samples and equilibrated with the
non-labelled uric acid. The labelled and the non-
labelled uric acid were then extracted from the serum
by the use of an anion exchange resin, a simple
Chromatographie step by which a number of subtances
in human serum e.g. proteins and lipophilic com-
pounds are removed. For gas liquid chromatography
the uric acid molecule has to be converted into a
stable volatile derivative. As described in the previous
report of hman (10), the trimethylsilyl derivative
proved to be most suitable. In order to obtain
only one out of several possible isomers, which are
probably formed because of various tautomeric forms
of the uric acid molecule, it is important to evaporate
a solution of the compound before derivative form-
ation in the presence of alkali, preferably methanolic
ammonia. The trimethylsilyl derivative then gives a
single peak in gas liquid chromatography. The mass
spectrum of the compound obtained after electron
impact Ionisation which is shown in figure l reveals a
molecular ion at m/z 456 indicating that the derivative
contains 4 trimethylsilyl groups. The molecular ion
shows high relative intensity which makes it possible
to record the uric acid derivative with high sensitivity
when the mass spectrometer is adjusted to this m/z-
value in the selected ion monitoring mode. In view of
this it seemed unnecessary to use more complicated
ionisation techniques e. g. chemical ionisation. After
processing a serum sample and injecting the tri-
methylsilyl derivative into the gas chromatography-
mass spectrometry System (set at m/z-values 456
and 458) selected ion recordings of the non-labelled
and the isotopically labelled uric acid derivatives are
obtained. As it may be seen from figure 2, in addition
to the two peaks of interest, no further compounds
are recorded. This indicates the high specificity of the
detection procedure. This high specificity is one of
the most important features, which makes it possible
to apply the selected ion monitoring technique for the
development of a definitive method. Furthermore it
appears mandatory to use a purification procedure
before mass spectrometry, which offers the highest
Separation power currently available. Thus, high per-
formance capillary gas liquid chromatography on
fused silica, a technique which is superior even to high
Performance liquid chromatography,.was selected s
the method of choice. Furthermore it should be noted
that a gas liquid capillary column may be easily
coupled to the mass spectrometer, whereas com-
plicated interfaces are needed to combine high per-
formance liquid chromatography with mass spec-
trometry.
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Fig. 1. Mass spectrum (Computer print) of the trimethylsilyl derivative of uric acid. For conditions of recording see Instruments
and Settings.
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Fig. 2. Selected ion recording (Computer print) of the trimethylsilyl derivative of uric acid (upper panel) and of [l,3-15NJuric acid
(lower panel) after processing a serum sample. For experimental details see Materials and Procedure.
For the calculation of the analytical results a set of
Standards was analysed whose isotope ratios were
closely related to those of the serum samples. As it is
good analytical practice, Standards and samples were
injected alternately. The non-labelled uric acid, due
to the natural isotope composition of the chemical
elements, contributes to a certain extent to the re-
cording of the labelled substance. This results in a
non-linear calibration function. Furthermore it should
be noted that the labelled uric acid contains a small
amount of the non-labelled substance. Taking these
facts into consideration, the calculation of the results
was carried out by a procedure which is based on
well-founded theoretical fundamentals (13,15) rather
than on an empiric calibration curve s described in
an earlier investigation (10).
Despite the considerable adavantages of the technique
described here there remain some very sniall sources
of unpredictible error in the final results. First, there
is an overall imprecision of the method in the r nge
from 0.6 to 1.1% (coefficient of Variation from day
to day), which is caused by the imprecision of the
isotope ratio measurement with the mass spectrometer
and the limited precision of pipetting sera and Stan-
dards. Second, there may be a small systematic error
which is due to a possible inaccuracy of the uric acid
content in the certified reference material (99.7%)
which is less than 0.1% s stated by the National
Bureau of Standards.
Apart from these neglegible sources of error the
accuracy of a clinical chemical method in general
depends on two different criteria of reliability. The
first is the specificity of the analytical method. It can
be stated that the selected ion monitoring technique
s applied here for the measurement of uric acid
provides the most specific procedure for the detection
of volatile substance in biological fluids. A second
crucial point with regard to accuracy of a clinical
chemical method is the recovery of a substance during
an analytical procedure. Even a highly specific method
will produce inacc rate results if the losses of sub-
stance cannot be determined accurately. The most
reliable procedure for monitoring recovery is the
isotope dilution technique. The selected ion mon-
itoring technique provides tfee most s itable means for
monitoring recovery during the analytical proced re.
the analytical losses are not only monitored during
the pre-instrumental part of tfce analyses biit also
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during the final detection process, since the labelled
and the non-labelled substance are recorded sim-
ultaneously by using the same detection procedure.
Although there is no final proof of accuracy for any
clinical chemical method, it can be assumed that the
procedure reported here, which is based on the isotope
dilution principle in combination with the selected
ion monitoring technique, provides the most suitable
means for the definitive measurement of uric acid in
human serum.
The method presented here has been in use for the
past two years for the measurement of uric acid in the
control sera of the Deutsche Gesellschaft für Klinische
Chemie.
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